Back

The impact of cirrhosis on the inflammatory milieu before and long-term after hepatitis C virus elimination by direct-acting antiviral therapy

Witte, M.; Oltmanns, C.; Tauwaldt, J.; Schmaus, H.; Mischke, J.; Grabert, G.; Bretthauer, M.; Deterding, K.; Maasoumy, B.; Wedemeyer, H.; Kacprowski, T.; Kraft, A. R. M.; Cornberg, M.

2023-10-31 infectious diseases
10.1101/2023.10.31.23297828 medRxiv
Show abstract

Background and AimsChronic hepatitis C virus (HCV) infection can lead to cirrhosis, development of hepatocellular carcinoma (HCC) and several extrahepatic manifestations. A sustained virological response (SVR) is achieved with direct-acting antivirals (DAA) in over 95% of the patients, but sequelae do not improve in all patients, suggesting permanent biological alterations induced by HCV infection. Therefore, we investigated the influence of chronic HCV infection, viral elimination and cirrhosis on inflammatory immune mediators. Approach and ResultsIn 102 chronic HCV patients, 46 with and 56 without cirrhosis, 92 soluble immune mediators (SIM) were measured in plasma samples at therapy start, end of treatment and long-term follow-up (median 96 weeks). 39 HBsAg positive persons with HBeAg negative infection served as controls. At baseline, 42 SIM were altered in chronic HCV patients (adj.p <0.05). Notably, patients with cirrhosis displayed a higher frequency and severity of alterations. At long-term follow-up, the SIM profile of the non-cirrhotic patients recovered to the level of the control group, while 41 SIM remained altered in cirrhotic patients. 33 of these SIM correlated with elastography, among them SIM linked to carcinogenesis as e.g. HGF, IL8 and IL6 (KEGG Pathways hsa05202, hsa05200). ConclusionsHCV-related changes in the inflammatory milieu can persist even after HCV elimination, specifically in cirrhotic patients. These changes are closely associated with liver damage and carcinogenesis. Our findings underscore the need for HCV elimination before extensive liver injury occurs and suggest further investigation of the relationship between persistent inflammatory milieu changes and long-term sequelae after HCV elimination. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/23297828v1_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@3a885borg.highwire.dtl.DTLVardef@ce3eb1org.highwire.dtl.DTLVardef@7601f6org.highwire.dtl.DTLVardef@17ad655_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of Hepatology
21 papers in training set
Top 0.1%
31.1%
2
JHEP Reports
11 papers in training set
Top 0.1%
18.5%
3
Frontiers in Immunology
638 papers in training set
Top 2%
6.7%
50% of probability mass above
4
iScience
1154 papers in training set
Top 5%
3.5%
5
Scientific Reports
3612 papers in training set
Top 30%
3.4%
6
eBioMedicine
183 papers in training set
Top 0.9%
3.2%
7
Nature Communications
5641 papers in training set
Top 40%
2.4%
8
eLife
5828 papers in training set
Top 41%
2.4%
9
Gut
40 papers in training set
Top 0.5%
1.9%
10
RNA Biology
78 papers in training set
Top 0.7%
1.7%
11
International Journal of Molecular Sciences
494 papers in training set
Top 9%
1.4%
12
PLOS ONE
5266 papers in training set
Top 55%
1.1%
13
EMBO Molecular Medicine
95 papers in training set
Top 2%
1.0%
14
Frontiers in Medicine
120 papers in training set
Top 4%
1.0%
15
Life Science Alliance
285 papers in training set
Top 6%
1.0%
16
Communications Medicine
113 papers in training set
Top 5%
0.8%
17
BMC Infectious Diseases
133 papers in training set
Top 5%
0.8%
18
Cell Reports Medicine
153 papers in training set
Top 5%
0.8%
19
Hepatology
22 papers in training set
Top 0.4%
0.8%
20
Clinical and Experimental Immunology
12 papers in training set
Top 0.1%
0.8%
21
Diabetes, Obesity and Metabolism
22 papers in training set
Top 0.9%
0.6%
22
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 4%
0.6%
23
Journal of Clinical Microbiology
130 papers in training set
Top 1%
0.6%
24
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.6%
25
JCI Insight
277 papers in training set
Top 9%
0.6%
26
The Journal of Pathology
26 papers in training set
Top 1%
0.6%
27
Viruses
332 papers in training set
Top 5%
0.6%
28
Cells
249 papers in training set
Top 8%
0.6%